# E6(R3) Good Clinical Practice: Annex 2 - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/e6r3-good-clinical-practice-annex-2/8cba2156-b613-4d5b-9a03-bb5b0bc681c1

> FDA guidance document: E6(R3) Good Clinical Practice: Annex 2. Issue date: December 30, 2024. Get complete insights and analysis.

---

## Details

- Title: E6(R3) Good Clinical Practice: Annex 2
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-12-30
- Comment Close Date: 2025-02-28
- Last Changed: 2024-12-30
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2024-D-5601">FDA-2024-D-5601</a>

## Related Documents

- [E20 Adaptive Designs for Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e20-adaptive-designs-for-clinical-trials/ea1da55a-c7ba-4a8a-bf9e-cfd6180b966c)
- [M15 General Principles for Model-Informed Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/m15-general-principles-for-model-informed-drug-development/0c262249-637c-4377-ac7f-9fc2fa0ab688)
- [M11 Clinical Electronic Structured Harmonised Protocol](https://www.globalkeysolutions.net/guidances/guidance-document/m11-clinical-electronic-structured-harmonised-protocol/08512de5-c7ff-456b-b915-b60eff6e9560)